Ronald P Gladue Selected Research

quinoxaline-2-carboxylic acid (4- carbamoyl- 1- (3- fluorobenzyl)- 2,7- dihydroxy- 7- methyloctyl)amide

1/2010	CCR1 antagonists: what have we learned from clinical trials.
1/2007	Phase I evaluation of the safety, pharmacokinetics and pharmacodynamics of CP-481,715.
3/2006	The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice.
10/2003	CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald P Gladue Research Topics

Disease

4	Inflammation (Inflammations) 03/2008 - 02/2002
3	Rheumatoid Arthritis 01/2010 - 10/2003
3	Multiple Sclerosis 01/2010 - 10/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2011
1	Neoplasms (Cancer) 07/2011
1	Atherosclerosis 02/2010
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2010
1	Infections 02/2007
1	Hypersensitivity (Allergy) 03/2006
1	Autoimmune Diseases (Autoimmune Disease) 05/2004

Drug/Important Bio-Agent (IBA)

4	quinoxaline-2-carboxylic acid (4- carbamoyl- 1- (3- fluorobenzyl)- 2,7- dihydroxy- 7- methyloctyl)amideIBA 01/2010 - 10/2003
2	ChemokinesIBA 02/2007 - 10/2003
1	selicrelumabIBA 07/2011
1	CCR2 ReceptorsIBA 02/2010
1	BX 471IBA 01/2010
1	AZD-4818IBA 01/2010
1	MLN3897IBA 01/2010
1	HaptensIBA 03/2008
1	AntigensIBA 02/2007
1	Antiviral Agents (Antivirals)IBA 02/2007
1	CytokinesIBA 03/2006
1	Interleukin-2 (IL2)IBA 03/2006
1	LigandsIBA 11/2004
1	Chemokine ReceptorsIBA 05/2004
1	CCR1 ReceptorsIBA 10/2003
1	LeukotrienesIBA 02/2002
1	Histamine (Histamine Dihydrochloride)FDA Link 02/2002